✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals

Infinium Pharmachem Ltd.

INFINIUM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹393 Cr.
P/E
48.22

Infinium Pharmachem Ltd.

  • Infinium Pharmachem
  • Neptune Petrochem.
  • Keltech Energies

FAQs on Infinium Pharmachem Ltd. Shareprice

Infinium Pharmachem has given lower returns compared to its competitors.
Infinium Pharmachem has grown at ~-19.88% over the last 1yrs while peers have grown at a median rate of -16.0%

Infinium Pharmachem is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Infinium Pharmachem is 48.22, while 3 year average PE is 37.44.
Also latest EV/EBITDA of Infinium Pharmachem is 14.51 while 3yr average is 15.77.

View FAQ's On Business

Growth Table

  • Infinium Pharmachem Ltd.
  • Neptune Petrochem.
  • Keltech Energies

Balance Sheet

  • Infinium Pharmachem Ltd.
  • Neptune Petrochem.
  • Keltech Energies

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Infinium Pharmachem Ltd.
  • Neptune Petrochem.
  • Keltech Energies

Cash Flow

  • Infinium Pharmachem Ltd.
  • Neptune Petrochem.
  • Keltech Energies

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Infinium Pharmachem Ltd.
  • Neptune Petrochem.
  • Keltech Energies

Quarterly Results

  • Infinium Pharmachem Ltd.
  • Neptune Petrochem.
  • Keltech Energies

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Infinium Pharmachem Ltd. Financials

Balance sheet of Infinium Pharmachem is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Infinium Pharmachem is decreasing.
Latest net debt of Infinium Pharmachem is -₹34.84 Crs as of Mar-25.
This is less than Mar-24 when it was -₹11.92 Crs.

The profit is oscillating.
The profit of Infinium Pharmachem is ₹7.84 Crs for TTM, ₹11.3 Crs for Mar 2024 and ₹9.49 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Infinium Pharmachem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech